answer text |
<p>The Government supports research into common and rare diseases through the National
Institute for Health Research (NIHR). In 2016 my Rt. hon. Friend the Secretary of
State for Health and Social Care announced a £816 million investment in the NIHR Biomedical
Research Centres, over five years from 1 April 2017, which has been awarded to 20
leading National Health Service and university partnerships across England. Each of
the 20 NIHR Biomedical Research Centres hosts the development of new, ground-breaking
treatments, diagnostics, prevention and care for patients in a wide range of diseases
and has considerable expertise, capacity and activity in research for rare diseases.</p><p>
</p><p>The NIHR Clinical Research Network is available to support the set-up and timely
delivery of commercial and non-commercial studies and trials in England which would
include studies on rare diseases.</p><p> </p><p>Rare diseases patients also benefit
from the pioneering research as part of the 100,000 Genomes Project. As of late 2017,
over 2,000 researchers in 342 United Kingdom and international institutions were part
of Genomics England’s Clinical Interpretation Partnership, which have been set up
improve understanding of genomic medicine and its application to healthcare; improve
understanding of diseases; and lead the way to developing new diagnostics and treatments.</p>
|
|